There is a page where you can see the short trade in Epicept. But you my change the name "shorters" to what ever suits you.
My text is a describtion over the latest development of a core of signatures that only writes about Epicept, acctually for years now.
The shorters in Sweden have made hara-kiri.
First the argued against dilution, saying nobody would ever give Epicept a credit. Sales is to vague in the future.
Now we have a loan, the argue that it must be payed back... Confronted with
(1) the cash in the CO is the double of the lended amount, some 18 MUSD.
(2) that the Amiket deal will at least double that figure
(3) sales will start after the reimbursment deals in the EU...
...they retreated to the position that Nasdaq will not give Epicept allowance for a new period.
Now they have had a very explicit release telling us a different story from Nasdaq point of view.
We do not know how many acctual living persons that really exist behind these signatures, but they now have to extend their efforts.
Is it all reminiscenses from dark Maxim ages? Let's hope there i s a reason, it really starts looking more than a hung up, so to say.
In sum Talley's annual cash-in is far beyond that. He gets that for years for burning our stockholder money. His only merit: Reducing the share price about 99% for creating self service money for his pocket.
Right, on top of the “base salary”of Talley also come bonus payment + options + incentives + car + severance package, and presumably a number of hidden benefits. Together that is much more than a million $ per year.
For what do stockholders pay this cheeky no-good ? For delivering a pack of lies and a busted share price